Nyxoah’s Genio(R) Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
Nyxoah's Genio(R) Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule GlobeNewswire November 26, 2025 Nyxoah's Genio(R) Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule Assignment to New Technology APC 1580 is positive news for Nyxoah's U.S. commercial rollout by strengthening hospital and ASC economics Mont-Saint-Guibert, Belgium – November 26, […]